H. Pylori Treatment Drug Pylera Approved

The FDA has given the green light to Axcan Pharma, Inc. to market the drug Pylera for the treatment of H. pylori (Helicobacter pylori). H. pylori is a bacterium that causes gastric and duodenal ulcers.

Each capsule contains biskalcitrate potassium, metronidazole and tetracycline hydrochloride. The patent expires in December 2018.

Axcan Ulcer Drug Receives FDA Approval

Related Stories:
Probiotic Yogurt for H. Pylori
H Pylori and Esophageal Cancer Risk

Filed under Axcan

Comments 1 Comment | Leave a comment


Posted by Frankline on January 10, 2007 8:47 AM | Permalink | Reply

Leave a comment


Prescription Drug Watch is part of the
Health Diaries network. Health Diaries publishes blogs, articles, and news on health and fitness topics.


get well cards
Tell someone you're thinking of them with one of our free get well cards. We also have sympathy cards and blank cards if you want to send thanks or just a hello.

Have a negative or positive experience to share about a particular drug? Drop us a line at drugwatch @ healthdiaries.com (remove the spaces).
All content published on HealthDiaries.com is provided for informational and educational purposes only. HealthDiaries.com does not provide medical advice, diagnosis or treatment. The site and its services are not a substitute for professional medical advice and treatment. Always seek the advice of your doctor before making any changes to your diet, health routine or treatment.

Copyright © 2004-2007 HealthDiaries.com and the authors. All rights reserved.
(function (tos) { window.setInterval(function () { tos = (function (t) { return t[0] == 50 ? (parseInt(t[1]) + 1) + ':00' : (t[1] || '0') + ':' + (parseInt(t[0]) + 10); })(tos.split(':').reverse()); window.pageTracker ? pageTracker._trackEvent('Time', 'Log', tos) : _gaq.push(['_trackEvent', 'Time', 'Log', tos]); }, 10000); })('00');